# Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

> **NCT03235024** · PHASE2 · COMPLETED · sponsor: **AOBiome LLC** · enrollment: 122 (actual)

## Conditions studied

- Atopic Dermatitis Eczema

## Interventions

- **BIOLOGICAL:** B244
- **BIOLOGICAL:** Vehicle

## Key facts

- **NCT ID:** NCT03235024
- **Lead sponsor:** AOBiome LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2019-02-27
- **Final completion:** 2019-03-20
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2022-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03235024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03235024, "Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03235024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*